JP2025170345A5 - - Google Patents

Info

Publication number
JP2025170345A5
JP2025170345A5 JP2025138496A JP2025138496A JP2025170345A5 JP 2025170345 A5 JP2025170345 A5 JP 2025170345A5 JP 2025138496 A JP2025138496 A JP 2025138496A JP 2025138496 A JP2025138496 A JP 2025138496A JP 2025170345 A5 JP2025170345 A5 JP 2025170345A5
Authority
JP
Japan
Prior art keywords
nucleic acid
receptor
vector
cells
sequence encoding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025138496A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025170345A (ja
Filing date
Publication date
Priority claimed from GBGB2005331.0A external-priority patent/GB202005331D0/en
Priority claimed from GBGB2017358.9A external-priority patent/GB202017358D0/en
Priority claimed from PCT/GB2021/050866 external-priority patent/WO2021205176A2/en
Application filed filed Critical
Publication of JP2025170345A publication Critical patent/JP2025170345A/ja
Publication of JP2025170345A5 publication Critical patent/JP2025170345A5/ja
Pending legal-status Critical Current

Links

JP2025138496A 2020-04-09 2025-08-21 細胞 Pending JP2025170345A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB2005331.0 2020-04-09
GBGB2005331.0A GB202005331D0 (en) 2020-04-09 2020-04-09 Cell
GBGB2017358.9A GB202017358D0 (en) 2020-11-02 2020-11-02 Cell
GB2017358.9 2020-11-02
PCT/GB2021/050866 WO2021205176A2 (en) 2020-04-09 2021-04-08 Cell
JP2022561019A JP7755597B2 (ja) 2020-04-09 2021-04-08 細胞

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022561019A Division JP7755597B2 (ja) 2020-04-09 2021-04-08 細胞

Publications (2)

Publication Number Publication Date
JP2025170345A JP2025170345A (ja) 2025-11-18
JP2025170345A5 true JP2025170345A5 (https=) 2026-01-13

Family

ID=75539696

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022561019A Active JP7755597B2 (ja) 2020-04-09 2021-04-08 細胞
JP2025138496A Pending JP2025170345A (ja) 2020-04-09 2025-08-21 細胞

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022561019A Active JP7755597B2 (ja) 2020-04-09 2021-04-08 細胞

Country Status (7)

Country Link
US (1) US20230113183A1 (https=)
EP (1) EP4132963A2 (https=)
JP (2) JP7755597B2 (https=)
CN (1) CN115315439A (https=)
AU (1) AU2021253759A1 (https=)
CA (1) CA3174812A1 (https=)
WO (1) WO2021205176A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201720949D0 (en) 2017-12-15 2018-01-31 Autolus Ltd Cell
JP2024541501A (ja) * 2021-11-25 2024-11-08 ドイチェス クレブスフォルシュンクスツェントルム スチフトゥング デス エッフェントリヒェン レヒツ Ｃｄ９５ポリペプチド

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7052906B1 (en) 1999-04-16 2006-05-30 Celltech R & D Limited Synthetic transmembrane components
IL145918A0 (en) * 2001-10-14 2002-07-25 Ares Trading Sa Method and kit for monitoring recruitment of proteins to the intracellular domain of a receptor in intact cells
US9931386B2 (en) * 2008-06-16 2018-04-03 Atsuo Ochi Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
GB201206559D0 (en) 2012-04-13 2012-05-30 Ucl Business Plc Polypeptide
CA2978186A1 (en) * 2015-03-05 2016-09-09 Fred Hutchinson Cancer Research Center Immunomodulatory fusion proteins and uses thereof
CA2999037A1 (en) * 2015-09-23 2017-03-30 Cytoimmune Therapeutics, LLC Flt3 directed car cells for immunotherapy
AU2018236461B2 (en) * 2017-03-17 2025-03-27 Fred Hutchinson Cancer Center Immunomodulatory fusion proteins and uses thereof
GB201716728D0 (en) * 2017-10-12 2017-11-29 Autolus Ltd Cell
GB201720949D0 (en) * 2017-12-15 2018-01-31 Autolus Ltd Cell
EP3810753A1 (en) * 2018-06-19 2021-04-28 Autolus Limited Cell
CA3114788A1 (en) * 2018-09-28 2020-04-02 Memorial Sloan-Kettering Cancer Center Immunoresponsive cells expressing dominant negative fas and uses thereof

Similar Documents

Publication Publication Date Title
JP2025170345A5 (https=)
Burnside et al. Immune-evasive gene switch enables regulated delivery of chondroitinase after spinal cord injury
RU2499599C2 (ru) Конструкции терапевтического переключения генов и биореакторы для экспрессии биотерапевтических молекул и их применение
JP2024096899A5 (https=)
DE60038011T2 (de) Verbesserung der immunantwort als anwendung in impfstoff und gentherapie
CN114807142B (zh) 一种环状RNA-circ-Magi1及其应用
US20130236428A1 (en) Reprogramming of Aged Adult Stem Cells
RU99101121A (ru) Полипептиды, способные к образованию антигенсвязывающих структур со специфичностью к резус-d-антигенам, днк, кодирующая их, способы их получения и применение
CN117337329A (zh) 环状rna
CA3234404A1 (en) Treatment with genetically modified cells, and genetically modified cells per se, with increased competitive advantage and/or decreased competitive disadvantage
JP7555583B2 (ja) 母児間免疫寛容を誘導する方法
US20150023935A1 (en) Reprogramming of Aged Adult Stem Cells
JP2024023268A5 (https=)
JPWO2021136263A5 (https=)
CN102876700A (zh) PiggyBac转座子介导的肌肉特异表达A-FABP通用载体构建
DE69836484T2 (de) Endogenes Retrovirales Genomnukliinelement, das mit einer Autoimmunkrankheit und/oder Schwengerschaftsstörungen verbunden ist, Verwendung als Marker
CN102002493B (zh) 小rna-326制备药物的应用
CN107034227A (zh) 防治牙周炎的dna疫苗
WO2025102927A1 (zh) 一种清除IgG/IgM抗体或B细胞药物的应用
CA2694222C (en) Insulin secretion inducer, and accelerator for increasing the number of pancreatic .beta.-cells
JP3410738B2 (ja) ミクログリアからなる医薬用キャリアー
JPWO2021205176A5 (https=)
DE10108626A1 (de) Verfahren zur Identifizierung biologisch aktiver Strukturen mikrobieller Erreger
JP2021516668A5 (https=)
CA3246480A1 (en) POLYNUCLEOTIDES OPTIMIZED FOR PROTEIN EXPRESSION